Submitted by Sorin61 t3_z563cl in technology
H2AK119ub t1_ixuy1j6 wrote
Reply to comment by throwawayagain31 in Brain cancer vaccine succeeds at prolonging survival in Phase 3 trial by Sorin61
I don't really understand your points. Current IO therapies don't work in GBM because it is a very heterogenous tumor type (not clonal like heme is) and there are few T cells in the brain for the MOA of checkpoint inhibitors to work. TAM reeducation is the closest a generic, non-personalized IO therapy could have for a decent shot on goal in this indication.
throwawayagain31 t1_ixv1cz0 wrote
Great points. I make some assumptions not really based in much research about glimpses just from personal experiences. You’re right in that it is a generic approach but it is wholly personalized from the POV that it’s utilizing the specific patient’s cells.
Viewing a single comment thread. View all comments